Regeneron Investigational Site 1 — Phoenix, Arizona

Regeneron Investigational Site 1 is a clinical research site located in Phoenix, Arizona, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Regeneron Investigational Site 1 has participated in 1 clinical trials.

Therapeutic areas: Neovascular Age-Related Macular Degeneration.

Sponsors: Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Regeneron Investigational Site 1?

Regeneron Investigational Site 1 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Regeneron Investigational Site 1 conducted?

Regeneron Investigational Site 1 has 1 clinical trials on record. Their work covers Neovascular Age-Related Macular Degeneration.

Is Regeneron Investigational Site 1 accredited by Crixeo Health?

Regeneron Investigational Site 1 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Regeneron Investigational Site 1?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.